Biosphere tenant Iksuda Therapeutics raises $47m to reinforce Antibody Drug Conjugate pipeline

by | Jun 7, 2021 | , , | 0

UK – UK-headquartered Iksuda Therapeutics has announced the closing of a $47m (£34m)...

Read More